Pronova says new plant will help it meet higher Omacor/Lovaza demand

Pronova BioPharma ASA has completed construction of a new plant in Denmark which will enable it to meet higher demand for its omega-3 derived prescription drug for hypertriglyceridemia, Omacor/Lovaza.